We are live on ! Find out more
Citigroup

Citigroup Portfolio holdings

AUM $235B
1-Year Est. Return 32.99%
 

Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.

This Fund
S&P 500
This Quarter Est. Return
+4.22%
1 Year Est. Return
+32.99%
3 Year Est. Return
+97.19%
5 Year Est. Return
+117.91%
10 Year Est. Return
+456.21%
AUM
$169B
AUM Growth
-$4.07B
Cap. Flow
-$7.85B
Cap. Flow %
-4.66%
Top 10 Hldgs %
20.89%
Holding
6,077
New
429
Increased
3,227
Reduced
1,533
Closed
263

Top Sells

Rank Stock Value
1
CAT icon
Caterpillar
CAT
+$755M
2
MSFT icon
Microsoft
MSFT
+$674M
3
AAPL icon
Apple
AAPL
+$642M
4
FLUT icon
Flutter Entertainment
FLUT
+$572M
5
NVDA icon
NVIDIA
NVDA
+$512M

Sector Composition

Rank Sector Weight
1 Technology 17.64%
2 Consumer Discretionary 7.06%
3 Financials 6.47%
4 Healthcare 4.72%
5 Communication Services 4.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IWY icon
5151
iShares Russell Top 200 Growth ETF
IWY
$15.7B
$15.5K ﹤0.01%
66
-124
-65% -$28.5K
PRAX icon
5152
CALL
Praxis Precision Medicines
PRAX
$8.8B
$15.4K ﹤0.01%
+200
New +$14.5K
GBF icon
5153
iShares Government/Credit Bond ETF
GBF
$133M
$15.3K ﹤0.01%
150
HYHG icon
5154
ProShares High Yield-Interest Rate Hedged ETF
HYHG
$182M
$15.3K ﹤0.01%
233
VTC icon
5155
Vanguard Total Corporate Bond ETF
VTC
$1.72B
$15.1K ﹤0.01%
200
+100
+100% +$7.72K
RSPS icon
5156
Invesco S&P 500 Equal Weight Consumer Staples ETF
RSPS
$249M
$15.1K ﹤0.01%
500
ARTW icon
5157
Arts-Way Manufacturing Co
ARTW
$12.4M
$14.9K ﹤0.01%
+6,858
New +$11.6K
GCTS
5158
GCT Semiconductor Holding
GCTS
$180M
$14.6K ﹤0.01%
6,254
+793
+15% +$2K
GREK
5159
Global X MSCI Greece ETF
GREK
$292M
$14.5K ﹤0.01%
373
TASK icon
5160
TaskUs
TASK
$531M
$14.4K ﹤0.01%
852
+668
+363% +$9.58K
ALLR
5161
Allarity Therapeutics
ALLR
$19.6M
$14.4K ﹤0.01%
+12,294
New +$16.3K
LMFA
5162
DELISTED
LM Funding America
LMFA
$13.7K ﹤0.01%
+256
New +$17.6K
TOVX icon
5163
Theriva Biologics
TOVX
$9.78M
$13.6K ﹤0.01%
+7,756
New +$11.3K
IVDA icon
5164
Iveda Solutions
IVDA
$2.7M
$13.5K ﹤0.01%
+2,740
New +$5.65K
PRF icon
5165
Invesco FTSE RAFI US 1000 ETF
PRF
$9.76B
$13.5K ﹤0.01%
335
LUCK
5166
Lucky Strike Entertainment
LUCK
$963M
$13.5K ﹤0.01%
1,348
-6,010
-82% -$68.9K
SMSI icon
5167
Smith Micro Software
SMSI
$14.1M
$13.5K ﹤0.01%
+2,059
New +$9.52K
ONLN icon
5168
ProShares Online Retail ETF
ONLN
$63.1M
$13.4K ﹤0.01%
300
PBE icon
5169
Invesco Biotechnology & Genome ETF
PBE
$282M
$13.3K ﹤0.01%
200
-500
-71% -$34.5K
FDT icon
5170
First Trust Developed Markets ex-US AlphaDEX Fund
FDT
$1.27B
$13.3K ﹤0.01%
246
PVLA
5171
Palvella Therapeutics
PVLA
$2.03B
$13.3K ﹤0.01%
1,108
ASAI
5172
DELISTED
Sendas Distribuidora S.A. American Depositary Share (each representing five common shares)
ASAI
$13.2K ﹤0.01%
2,962
-6,656
-69% -$38.8K
IMTX icon
5173
Immatics
IMTX
$1.18B
$13.2K ﹤0.01%
1,861
+496
+36% +$4.26K
NUMV icon
5174
Nuveen ESG Mid-Cap Value ETF
NUMV
$449M
$13.2K ﹤0.01%
380
MERC icon
5175
Mercer International
MERC
$44.7M
$13.2K ﹤0.01%
2,034
-5,841
-74% -$38.2K

Similar funds

Citigroup's Q4 2024 Portfolio in Review

As of Q4 2024, Citigroup held 6,077 positions worth $169B, down 2.4% from $173B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Citigroup withdrew a net $7.85B in Q4 2024, closing 263 positions and reducing 1,533 holdings. Its most notable exit was Stericycle Inc, an estimated $125M position sold in full.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 18% a quarter earlier, followed by Consumer Discretionary and Financials.

Against the trend, Citigroup opened a new position in T-Rex 2X Long MSTR Daily Target ETF worth $19M.

  • Citigroup's largest Q4 2024 buy was T-Rex 2X Long MSTR Daily Target ETF: 249,467 shares worth $19M.
  • Citigroup added most to Jefferies Financial Group in Q4 2024, an estimated $460M increase.
  • Citigroup's biggest Q4 2024 reduction was Caterpillar, cutting an estimated $755M.
  • Citigroup fully exited Stericycle Inc in Q4 2024, selling an estimated $125M.
  • Citigroup's ten largest holdings make up 21% of its $169B portfolio in Q4 2024.
  • Citigroup opened 429 new positions and closed 263 in Q4 2024.
  • Citigroup's portfolio value fell 2.4% quarter-over-quarter to $169B.

Based on Citigroup's 13F filing for Q4 2024, filed 12 Feb 2025.